Synthesis and identification of some new n-substituted quinazoline-4-one, thiazine-4-one and tetrazoline rings incorporating n-ethyl-2-(Benzylthio)benzimidazole acetate and study their application as anti-oxidant agent
International Journal of Pharmaceutical Research, ISSN: 0975-2366, Vol: 12, Issue: 3, Page: 450-462
2020
- 2Citations
- 11Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
A new series of 2-Mercaptobenzimidazole derivatives were synthesized. Quinazoline-4-one, thiazine-4-one and Tetrazoline derivatives. These compounds can be prepared by alkylation of 2-Mercaptobenzimidazole [2-MBI] with benzyl chloride in basic medium to produce 2- benzyl thiobenzimidazole [1], then the compound [1] was mixed with sodium hydride in dioxane at (0-5C0) to give the salt of compound [1]. Then the salt was reacted with ethyl chloro acetate to yield ethyl 2-(benzylthio) benzimidazole acetate compound [2] as a starting compound [2]. Thereafter, compound [2] was treated with hydrazine hydrate to afford N-acetohydrazide-2-(benzyl thio) benzimidazole [3] then reacted with a different substitution aromatic aldehyde in absolute ethanol to give Schiff’s bases derivatives [4-10]. The reactions of compounds [4-10] were carried out through three pathways for cyclization: The first pathway involved a reaction with 2- amino benzoic acid to afford Quinazoline-4-one derivatives [11-17]. The second pathway consists of reaction with 2-marcaptobenzoic acid to produce thiazine-4-one derivatives [18-24]. The third pathway involved reaction with sodium azide to obtain tetrazoline derivatives [25-31]. The new prepared compounds were identified by [FTIR, 1H-NMR and 13C-NMR] and their physical properties were measured. Furthermore, we have evaluated of anti-oxidant activities in-vitro of the new synthesized compounds were tested with DPPH radical cation decolorization assays.
Bibliographic Details
SynthesisHub Advance Scientific Research
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know